DNA-based microarray studies in visceral leishmaniasis: identification of biomarkers for diagnostic, prognostic and drug target for treatment
Visceral leishmaniasis (VL) is one of the major infectious diseases affecting the poorest
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
DNA-based microarray studies in visceral leishmaniasis: identification of biomarkers for diagnostic, prognostic and drug target for treatment.
A Kumar, SC Pandey, M Samant - 2020 - cabidigitallibrary.org
Visceral leishmaniasis (VL) is one of the major infectious diseases affecting the poorest
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
DNA-based microarray studies in visceral leishmaniasis: identification of biomarkers for diagnostic, prognostic and drug target for treatment
A Kumar, SC Pandey, M Samant - Acta tropica, 2020 - pubmed.ncbi.nlm.nih.gov
Visceral leishmaniasis (VL) is one of the major infectious diseases affecting the poorest
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
DNA-based microarray studies in visceral leishmaniasis: identification of biomarkers for diagnostic, prognostic and drug target for treatment.
A Kumar, SC Pandey, M Samant - Acta Tropica, 2020 - europepmc.org
Visceral leishmaniasis (VL) is one of the major infectious diseases affecting the poorest
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …
regions of the world. Current therapy is not very much satisfactory. The alarming rise of drug …